Dr. Dongweon Song obtained his Ph.D. degree in the department of Molecular Pharmacology and Cancer Therapeutics, Roswell Park Cancer Institute Graduate Division, SUNY at Buffalo. Prior to joining the Center for Protein Therapeutics (CPT) post-doctoral program, he served as a post-doctoral research fellow in the GI Oncology Drug Development program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. While in the Balthasar Lab, Song explored the mechanism of action of intravenous immunoglobulins (IVIG) and defining the pharmacokinetics/pharmacodynamics of IVIG in immune thrombocytopenic purpura (ITP).